Dopaminergic inhibition of growth hormone and prolactinn release during continuous in vitro perifusion of normal and adenomatous human pituitary
- 1 February 1981
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 49 (2) , 229-239
- https://doi.org/10.1016/0022-510x(81)90081-2
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Hormone Secretion by Dispersed Cell Cultures of Human Pituitary Adenomas: Effects of Theophylline, Thyrotropin-Releasing Hormone, Somatostatin, and 2-Bromo-α-Ergocryptine*Journal of Clinical Endocrinology & Metabolism, 1979
- TESTS OF PROLACTIN SECRETION IN DIAGNOSIS OF PROLACTINOMASThe Lancet, 1979
- TRH and Dopamine Interactions Affecting Pituitary Hormone SecretionJournal of Clinical Endocrinology & Metabolism, 1977
- Bromocriptine treatment of acromegalyMetabolism, 1977
- Effect of Dopamine on Plasma Growth Hormone and Prolactin Levels in Normal and Acromegalic SubjectsJournal of Clinical Endocrinology & Metabolism, 1977
- Dopamine/Neuroleptic Receptors in Basal Hypothalamus and PituitaryEndocrinology, 1976
- APPLICATION OF AN IN-VITRO PERIFUSION TECHNIQUE TO STUDIES OF LUTEINIZING HORMONE RELEASE BY RAT ANTERIOR HEMI-PITUITARIES: SELF-POTENTIATION BY LUTEINIZING HORMONE RELEASING HORMONEJournal of Endocrinology, 1976
- Changes in Plasma Growth Hormone Levels in Normal and Acromegalic Subjects Following Administration of 2-Bromo-?-ErgocryptineJournal of Clinical Endocrinology & Metabolism, 1975
- EFFECT OF LEVODOPA (L-DOPA) ON HUMAN HYPOPHYSEAL TROPHIC HORMONE RELEASE1Journal of Clinical Endocrinology & Metabolism, 1971
- Human growth hormone in cultures of human pituitary tumorsJournal of Neurosurgery, 1971